NVCR: NovoCure Limited Stocks News on December 24, 2024

Novocure price target raised to $42 from $28 at Piper Sandler

NVCR

TipRanks

10 days ago

Novocure price target raised to $42 from $28 at Piper Sandler

Why NovoCure Stock Was Winning Big This Week

NVCR

Motley Fool

18 days ago

Why NovoCure Stock Was Winning Big This Week

Novocure Has Already Doubled in 2024. Can It Soar Higher in 2025?

NVCR

Motley Fool

19 days ago

Novocure Has Already Doubled in 2024. Can It Soar Higher in 2025?

NVCR

Investor's Business Daily

21 days ago

Novocure Stock Earns 96 RS Rating

NVCR

Zacks

21 days ago

NVCR Stock Up as TTFields Therapy Meets Pancreatic Cancer Study Goals

Zai Lab, Novocure announce PANOVA-3 trial met primary endpoint

NVCR

TipRanks

21 days ago

Zai Lab, Novocure announce PANOVA-3 trial met primary endpoint

Novocure Launches 49% After Pancreatic Cancer Treatment Succeeds

NVCR

Investor's Business Daily

22 days ago

Novocure Launches 49% After Pancreatic Cancer Treatment Succeeds

Novocure seeks approval after pancreatic cancer wearable scores at Phase III

NVCR

Medical Device Network

22 days ago

Novocure seeks approval after pancreatic cancer wearable scores at Phase III

NVCR

Clinical Trials Arena

22 days ago

Novocure seeks approval after pancreatic cancer wearable scores at Phase III

NVCR

MT Newswires

22 days ago

Update: NovoCure's Shares Rise as Pancreatic Cancer Trial Meets Primary Endpoint

NovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer Patients

NVCR

Benzinga

22 days ago

NovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer Patients

Novocure's Stock Skyrockets Over 32% Amid Groundbreaking Pancreatic Cancer Therapy Success

NVCR

GuruFocus.com

22 days ago

Novocure's Stock Skyrockets Over 32% Amid Groundbreaking Pancreatic Cancer Therapy Success

Novocure Launches 40% After Pancreatic Cancer Treatment Succeeds

NVCR

Investor's Business Daily

22 days ago

Novocure Launches 40% After Pancreatic Cancer Treatment Succeeds

NVCR

MT Newswires

22 days ago

Zai Lab, NovoCure Say Pancreatic Cancer Trial Meets Primary Endpoint

NVCR

MT Newswires

22 days ago

Evercore ISI Upgrades NovoCure to Outperform

Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer

NVCR

Business Wire

22 days ago

Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer

Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer

NVCR

Business Wire

22 days ago

Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer

Novocure to Participate in Upcoming Investor Conferences

NVCR

Business Wire

a month ago

Novocure to Participate in Upcoming Investor Conferences

Novocure secures FDA approval for add-ons to brain cancer treatment wearable

NVCR

Medical Device Network

a month ago

Novocure secures FDA approval for add-ons to brain cancer treatment wearable

NVCR

MT Newswires

a month ago

NovoCure Gets FDA Nod for Updated Optune Gio Arrays

Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma

NVCR

Business Wire

a month ago

Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma

FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma

NVCR

Business Wire

a month ago

FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma

NovoCure’s Strong Q3 and Leadership Changes in 2024

NVCR

TipRanks

2 months ago

NovoCure’s Strong Q3 and Leadership Changes in 2024

NVCR

GuruFocus.com

2 months ago

NovoCure Ltd (NVCR) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ...

NVCR

Motley Fool

2 months ago

NovoCure (NVCR) Q3 2024 Earnings Call Transcript

NVCR

MT Newswires

2 months ago

NovoCure Names New Chief Financial Officer

NVCR

MT Newswires

2 months ago

NovoCure Q3 Loss Narrows, Net Revenue Increases

NVCR

Zacks

2 months ago

NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates

NVCR

Associated Press Finance

2 months ago

NovoCure: Q3 Earnings Snapshot

Novocure Appoints Christoph Brackmann as Chief Financial Officer

NVCR

Business Wire

2 months ago

Novocure Appoints Christoph Brackmann as Chief Financial Officer

Novocure Reports Third Quarter 2024 Financial Results

NVCR

Business Wire

2 months ago

Novocure Reports Third Quarter 2024 Financial Results

Novocure's Optune Lua Receives FDA Approval For Lung Cancer Treatment

NVCR

GuruFocus.com

2 months ago

Novocure's Optune Lua Receives FDA Approval For Lung Cancer Treatment

NVCR

Medical Device Network

2 months ago

NovoCure scoops FDA approval on wearable for metastatic cancer treatment

NVCR

Clinical Trials Arena

2 months ago

NovoCure scoops FDA approval on wearable for metastatic cancer treatment

Novocure Withdraws Massive Gain On FDA Approval. Why It Could Struggle To Gain Traction.

NVCR

Investor's Business Daily

2 months ago

Novocure Withdraws Massive Gain On FDA Approval. Why It Could Struggle To Gain Traction.

NVCR

MT Newswires

2 months ago

Sector Update: Health Care Stocks Rise Premarket Wednesday

NVCR

MT Newswires

2 months ago

Sector Update: Health Care

Novocure wins FDA approval for electric field device in lung cancer

NVCR

BioPharma Dive

2 months ago

Novocure wins FDA approval for electric field device in lung cancer

NVCR

MT Newswires

2 months ago

Top Premarket Gainers

FDA Approves NovoCure's Portable Device Producing Tumor-Treating Electric Fields For Previously Treated Lung Cancer Patients

NVCR

Benzinga

2 months ago

FDA Approves NovoCure's Portable Device Producing Tumor-Treating Electric Fields For Previously Treated Lung Cancer Patients

NVCR

MT Newswires

2 months ago

HC Wainwright Upgrades NovoCure to Buy From Neutral, Adjusts Price Target to $30 From $24

NVCR

Investing.com

2 months ago

Novocure shares soar 33% as FDA approves lung cancer treatment

NVCR

Zacks

2 months ago

NovoCure (NVCR) Surges 10.7%: Is This an Indication of Further Gains?

Novocure Shoots Skyward, Reversing Setbacks, After FDA Approves Lung Cancer Treatment

NVCR

Investor's Business Daily

2 months ago

Novocure Shoots Skyward, Reversing Setbacks, After FDA Approves Lung Cancer Treatment

NVCR

MT Newswires

2 months ago

NovoCure Says US FDA Approves Optune Lua to Treat Lung Cancer; Shares Jump After Hours

FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer

NVCR

Business Wire

2 months ago

FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer

Novocure to Report Third Quarter 2024 Financial Results

NVCR

Business Wire

3 months ago

Novocure to Report Third Quarter 2024 Financial Results

Novocure to Present Real-World Data at ESMO 2024 Demonstrating Improved Survival Outcomes for Newly Diagnosed Glioblastoma Patients with Increased Use of Tumor Treating Fields (TTFields) Therapy

NVCR

Business Wire

3 months ago

Novocure to Present Real-World Data at ESMO 2024 Demonstrating Improved Survival Outcomes for Newly Diagnosed Glioblastoma Patients with Increased Use of Tumor Treating Fields (TTFields) Therapy

Why NovoCure Stock Dived by 13% This Week

NVCR

Motley Fool

4 months ago

Why NovoCure Stock Dived by 13% This Week

NVCR

MT Newswires

4 months ago

NovoCure CEO Asaf Danziger to Retire, CFO Ashley Cordova Named Successor

Novocure Announces Planned CEO Transition

NVCR

Business Wire

4 months ago

Novocure Announces Planned CEO Transition

Novocure to Participate in 2024 Wells Fargo Healthcare Conference

NVCR

Business Wire

4 months ago

Novocure to Participate in 2024 Wells Fargo Healthcare Conference

NVCR

Zacks

4 months ago

Wall Street Analysts Think NovoCure (NVCR) Could Surge 35.96%: Read This Before Placing a Bet

Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer

NVCR

Business Wire

4 months ago

Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer

Biotech stocks: Which drugmakers are worth a buy?

NVCR

Yahoo Finance Video

4 months ago

Biotech stocks: Which drugmakers are worth a buy?

NVCR

Simply Wall St.

5 months ago

Even after rising 8.9% this past week, NovoCure (NASDAQ:NVCR) shareholders are still down 86% over the past three years

NVCR

Zacks

5 months ago

New Strong Buy Stocks for August 1st

NVCR

Zacks

5 months ago

Wall Street Analysts Believe NovoCure (NVCR) Could Rally 26.39%: Here's is How to Trade

NVCR

Motley Fool

5 months ago

NovoCure (NVCR) Q2 2024 Earnings Call Transcript

NVCR

MT Newswires

5 months ago

NovoCure Q2 Loss Narrows, Net Revenue Increases

NVCR

Zacks

5 months ago

NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates

NVCR

Associated Press Finance

5 months ago

NovoCure: Q2 Earnings Snapshot

Novocure Reports Second Quarter 2024 Financial Results

NVCR

Business Wire

5 months ago

Novocure Reports Second Quarter 2024 Financial Results

Novocure to Report Second Quarter 2024 Financial Results

NVCR

Business Wire

6 months ago

Novocure to Report Second Quarter 2024 Financial Results

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

NVCR

PR Newswire

6 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

NVCR

Business Wire

6 months ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts

NVCR

AFP

6 months ago

New Zealand scraps plan to tax livestock burps, farts

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

NVCR

The Wall Street Journal

6 months ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

NVCR

Business Wire

6 months ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

UK Unemployment Rises in Sign Inflationary Pressures Cool

NVCR

Bloomberg

6 months ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

NVCR

Simply Wall St.

6 months ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors

NVCR

Simply Wall St.

6 months ago

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

NVCR

Yahoo Finance Video

6 months ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

NVCR

GlobeNewswire

6 months ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

NVCR

Reuters

6 months ago

California seeks company profits in Big Oil climate lawsuit

NVCR

USA TODAY

6 months ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

NVCR

GlobeNewswire

6 months ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

NVCR

Business Wire

6 months ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

NVCR

Business Wire

6 months ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

NVCR

GlobeNewswire

6 months ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

$6.6 Billion Digital X-ray Market, 2024-2029: Development of AI-based Digital X-Ray Systems Present Business Opportunities

NVCR

GlobeNewswire

6 months ago

$6.6 Billion Digital X-ray Market, 2024-2029: Development of AI-based Digital X-Ray Systems Present Business Opportunities

2 Reasons to Buy Rivian Stock (and 1 Big Reason to Sell)

NVCR

Motley Fool

6 months ago

2 Reasons to Buy Rivian Stock (and 1 Big Reason to Sell)

DFR Gold Inc. Announces Amendment of WUO Land Option and Insider Loans

NVCR

CNW Group

6 months ago

DFR Gold Inc. Announces Amendment of WUO Land Option and Insider Loans

Walmart Stock Climbs After Dow Jones Giant Receives Upgrade, Major Price Target Hike

NVCR

Investor's Business Daily

6 months ago

Walmart Stock Climbs After Dow Jones Giant Receives Upgrade, Major Price Target Hike

EPCOR and HAWSCo Enter Ownership Transfer Agreement

NVCR

CNW Group

6 months ago

EPCOR and HAWSCo Enter Ownership Transfer Agreement

Video on Demand (VoD) Market Report 2024-2034: Netflix, Amazon, Google and Hulu Dominate

NVCR

GlobeNewswire

6 months ago

Video on Demand (VoD) Market Report 2024-2034: Netflix, Amazon, Google and Hulu Dominate

Southwest Airlines stock pops on report of Elliott's $2B stake

NVCR

Yahoo Finance Video

6 months ago

Southwest Airlines stock pops on report of Elliott's $2B stake

NVCR

Business Wire

6 months ago

Form 8.3 - Virgin Money UK plc

NVCR

MT Newswires

7 months ago

Wedbush Adjusts Price Target on NovoCure to $24 From $21, Maintains Neutral Rating

METIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial Progression with Improved Quality of Life Deterioration-Free Survival

NVCR

Business Wire

7 months ago

METIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial Progression with Improved Quality of Life Deterioration-Free Survival

TIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in Germany

NVCR

Business Wire

7 months ago

TIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in Germany

NVCR

Insider Monkey

8 months ago

NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript

NVCR

Motley Fool

8 months ago

NovoCure (NVCR) Q1 2024 Earnings Call Transcript

NVCR

MT Newswires

8 months ago

NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue

NVCR

GuruFocus.com

8 months ago

NovoCure Ltd (NVCR) Q1 2024 Earnings: Revenue Surpasses Estimates, Narrower Net Loss Reported

NVCR

Zacks

8 months ago

NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates

NVCR

Associated Press Finance

8 months ago

NovoCure: Q1 Earnings Snapshot

Novocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Financing from Pharmakon

NVCR

Business Wire

8 months ago

Novocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Financing from Pharmakon

Novocure Reports First Quarter 2024 Financial Results

NVCR

Business Wire

8 months ago

Novocure Reports First Quarter 2024 Financial Results

NVCR

Zacks

8 months ago

Latest NovoCure Limited (NVCR) News on December 24, 2024

Share on Social Networks: